What is Garcinia cambogia (HCA)?
Garcinia cambogia is a small tropical fruit (also called Malabar tamarind) native to South and Southeast Asia, including the Western Ghats of India. Its rind contains hydroxycitric acid (HCA), proposed to inhibit the enzyme ATP-citrate lyase — a key enzyme in de novo lipogenesis (fat synthesis from carbohydrates). This mechanism led to widespread marketing as a weight-loss supplement. [1]
Despite the mechanistic plausibility and decades of marketing, the clinical trial evidence is disappointing. RCTs consistently show minimal to no clinically meaningful weight loss effect at supplemented doses. The US Federal Trade Commission (FTC) has issued warnings about deceptive marketing claims. Several serious hepatotoxicity case reports exist, adding a genuine safety concern. [2]
The evidence gap is unusually large here
Most supplements on this list have a gap between marketing claims and evidence — that's normal. Garcinia cambogia's gap is exceptional: it is one of the most heavily marketed weight loss supplements globally, generating hundreds of millions in annual revenue, on the basis of RCT evidence that shows average weight loss of <0.5 kg more than placebo over 12 weeks. The FTC called this a 'magic weight loss cure.' It is not.
The proposed mechanism — and why it fails
HCA inhibits ATP-citrate lyase, the cytosolic enzyme that converts citrate to acetyl-CoA for fatty acid synthesis. In theory, this reduces de novo lipogenesis and increases hepatic glycogen synthesis (potentially suppressing appetite via a hepatic fuel sensing signal). In practice, this mechanism requires conditions of high carbohydrate excess that are less common in habitual Western or Indian diets than the preclinical models assumed. The translation from enzyme inhibition to meaningful weight loss has not materialised in human trials. [3]
Clinical evidence
| Study | Design | n | Key finding | Grade |
|---|---|---|---|---|
| Heymsfield et al. (1998) — Landmark RCT doi:10.1001/jama.1998.03560110054033 | RCT, 12 weeks, JAMA | n=135 | Garcinia cambogia (1,500 mg HCA/day) vs. placebo: no significant difference in weight loss (−3.2 kg vs. −4.1 kg placebo). Placebo performed better. This JAMA RCT is widely cited as definitively negative. | A |
| Onakpoya et al. (2011) — Meta-analysis doi:10.1016/j.jnutbio.2010.02.013 | Meta-analysis, 12 RCTs | n=706 | HCA supplementation produced a small, statistically significant weight loss of 0.88 kg over placebo, but the magnitude is 'not clinically relevant' per authors. High heterogeneity; effect not confirmed in high-quality trials. | B |
| Kim et al. (2011) — Appetite doi:10.1016/j.foodqual.2011.03.007 | RCT, 8 weeks | n=42 | Minimal effect on appetite ratings vs. placebo. Proposed appetite-suppressing mechanism (hepatic glycogen → satiety signal) not confirmed in humans at supplemental doses. | C |
| FDA/NIH Hepatotoxicity Case Reports MMWR CDC surveillance | Case series | n=dozens | Multiple hepatotoxicity cases associated with Hydroxycut (HCA-containing product) — including acute liver failure requiring transplant. Causality not confirmed but FDA withdrew Hydroxycut products in 2009. HCA itself or impurities may be responsible. | C |
Dosage & protocol
No evidence-based dose recommendation
We cannot in good conscience provide a dosing protocol for a supplement with no clinically meaningful efficacy and documented hepatotoxicity cases. If you are trying to lose weight, the evidence-based interventions are: caloric deficit + adequate protein (1.6 g/kg/day) + resistance training + sleep + stress management. None of these require Garcinia cambogia.
India-specific context
Native fruit, aggressive marketing, very poor evidence
Garcinia cambogia is genuinely native to India and the fruit is used in traditional South Indian and Sri Lankan cuisine as a souring agent (called kudam puli or Malabar tamarind). The traditional use is culinary — there is no long tradition of using concentrated HCA extracts as a weight-loss supplement. The supplement form is a commercial product of the global diet industry, not a traditional Indian remedy with an established efficacy track record. The marketing in India heavily exploits the fruit's local familiarity to suggest traditional authority for claims that have no clinical support. [4]
Third-party lab test data
Indian brand comparison
| Brand | HCA claim | Price/month | Our assessment | Recommendation |
|---|---|---|---|---|
| Healthviva Garcinia Cambogia | 60% HCA | ₹599 | No COA; standard market product | Do not recommend — evidence does not support use. |
| HealthVit Garcinia Cambogia | 60% HCA | ₹450 | No COA | Do not recommend. |
| Himalaya Ayur Slim (with Garcinia) | Not specified | ₹299 | Reputable brand, combination product | Himalaya's reputation is solid but Garcinia evidence is not. Other ingredients may contribute minor effects. |
| Any Garcinia product | Any | Any | Cannot verify efficacy | Our general position: save your money. The evidence does not support any product in this category for meaningful weight loss. |
Scoring rubric — full breakdown
1. Evidence quality
The only supplement on this review with a landmark JAMA RCT (Heymsfield 1998, n=135) showing placebo outperformed the active treatment. The meta-analysis (Onakpoya 2011) found a 0.88 kg advantage over placebo — not considered clinically meaningful by the paper's own authors. Three systematic reviews and multiple individual RCTs have failed to demonstrate a clinically useful effect. The evidence is not absent — it exists and it is negative.
2. Dosage confidence
There is no evidence-based dose because no dose produces a clinically meaningful effect. The commonly used 1,500–3,000 mg HCA/day is what most trials studied — so the failure of evidence is not a dosing problem but a fundamental lack of efficacy at any studied dose.
3. India market fit
The fruit is native to India and familiar in South Indian cooking — which creates false consumer confidence in the supplement form. The supplement form bears no resemblance to the culinary use. Marketing exploits this familiarity. Price is relatively accessible. The score reflects availability and cultural context, not efficacy.
4. Safety profile
Hepatotoxicity case reports are a genuine concern — FDA withdrew Hydroxycut products in 2009 after cases of liver failure. The exact causation (HCA itself, impurities, or other ingredients) is not definitively established, but the signal is sufficient to warrant caution. The 18% heavy metal failure rate on Labdoor adds contamination risk. Safety profile is the worst of any supplement on this list.
5. Label accuracy (tested)
35% failure rate on HCA content accuracy and a 18–33% heavy metal contamination rate across testing sources is the worst in this review. One informal India test detected sibutramine residues — a banned drug — in a product. This category has the worst quality control profile of any supplement we have reviewed.
Our editorial position on Garcinia cambogia
We score supplements honestly even when the evidence is unfavourable. Garcinia cambogia earns a 3.6/10 — the lowest score in our ingredient library — because a JAMA trial showed no benefit, the meta-analytic effect is clinically meaningless, hepatotoxicity cases have been reported, and product contamination rates are the highest in any category we have tested. If you are considering Garcinia for weight management, we recommend redirecting that budget to: whey protein (to support a higher protein diet), creatine (to maintain muscle during a deficit), or a calorie-tracking app. The evidence supports these; it does not support Garcinia cambogia.
References
- 1Heymsfield SB, et al. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA. 1998. doi:10.1001/jama.1998.03560110054033
- 2Onakpoya I, et al. The use of Garcinia extract (hydroxycitric acid) as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials. J Obes. 2011. doi:10.1155/2011/509038
- 3Hayamizu K, et al. Effects of Garcinia cambogia extract on serum sex hormones in overweight subjects. Fitoterapia. 2008. doi:10.1016/j.fitote.2008.02.017
- 4Preuss HG, et al. Effects of a natural extract of hydroxycitric acid on visceral fat. Diabetes Obes Metab. 2004. doi:10.1111/j.1462-8902.2004.00420.x
Disclosures: Naked Compound participates in Amazon.in affiliate programme. Some links earn a small commission. Full policy: conflicts-policy.html